Generex Biotech Presents Immunotherapeutics Study Results at the 41st Annual Meeting of the European Assoc for the Study of Diabetes
15th Sep 2005, 16:23 GMT
Generex Biotech Corp announced clinical trial results generated by Antigen Express Rome, Italy presented a study titled A Novel Approach to Study T Cell Response to Ii-Key/MHC Class II Epitope Hypbrid Peptides in Type 1 Diabetes.
Latest news from Nephrology/ Dialysis News from myHealthcareNews.com:
- New Data Show ACTOS Halted Progression of Atherosclerosis as Indicated by CIMT in Patients with Type 2 Diabetes
- Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study
- Aksys Reports Q3 2006 Financial Results
- Altus Pharmaceuticals Announces Presentation of ALTU-238 Phase II Data at Int'l Congress of Growth Hormone and Insulin-Like Growth Factor Research Societies
- Opexa Reports Q3 Financial Results
- Treatment of Diabetic Foot Ulcers Addressed at Upcoming American Heart Assoc Meeting
- Weight Loss Surgery Assists in Eliminating, Avoiding Type 2 Diabetes; American Institute of Gastric Banding Recognizes November as Nat'l Diabetes Month
- Federal Economic Development Agency Enlists Support of African-American Churches in the IL Delta
- Federal Economic Development Agency Enlists Support of African-American Churches in the MS Delta
- Federal Economic Development Agency Enlists Support of African-American Churches in the LA Delta